Efficacy of 5α-reductase inhibitors for patients with large benign prostatic hyperplasia (>80 mL) after transurethral resection of the prostate
Authors:
- 30 July 2015
- journal article
- research article
- Published by Taylor & Francis in The Aging Male
- Vol. 18 (4) , 238-243
Abstract
To prospectively evaluate 5α-reductase inhibitors (5αRIs) for benign prostatic hyperplasia (BPH) patients with a large prostate (>80 mL) after transurethral resection of the prostate (TURP). Eighty-seven patients were recruited from January 2007 to October 2014. Patients were randomized into a trial and a control group. The trial group was treated with 5αRIs for 3 years after TURP, while the control group received a placebo. We evaluated the indicators before, peri and after TURP. There were no significant differences in the indicators before and peri-TURP. Six months later, there were significant differences in PSA and hematuria (HU). Three years after TURP, there were significant differences in prostate volume (PV), level of prostate-specific antigen (PSA), the maximum flow rate (Qm), and HU between the trial and control groups. Additionally, there were significant differences in the PV, PSA, international prostate symptom score (IPSS), patient quality of life (QoL) in the trial group alone between those treated with finasteride and those treated with dutasteride. After TURP for large BPH, administration of 5αRIs for 3 years improved PV, PSA, Qm and HU. Additionally, dutasteride produced superior improvements in PV, PSA, IPSS and QoL compared with finasteride.Keywords
This publication has 18 references indexed in Scilit:
- Comparison of transurethral plasmakinetic and transvesical prostatectomy in treatment of 100–149 mL benign prostatic hyperplasiaAsian Journal of Surgery, 2014
- Management of large prostatic adenoma: Lasers versus bipolar transurethral resection of prostateIndian Journal of Urology, 2013
- Prevention and management of TURP-related hemorrhageNature Reviews Urology, 2011
- Conventional monopolar resection or bipolar resection in saline for the management of large (>60 g) benign prostatic hyperplasia: An evaluation of morbidityMinimally Invasive Therapy & Allied Technologies, 2010
- Bipolar Transurethral Resection in Saline System versus Traditional Monopolar Resection System in Treating Large-Volume Benign Prostatic HyperplasiaUrologia Internationalis, 2009
- Rapid Communication : Photoselective Vaporization of the Prostate versus Transurethral Resection of the Prostate for the Large Prostate: A Prospective Nonrandomized Bicenter Trial with 2-Year Follow-UpJournal of Endourology, 2008
- Complications of Transurethral Resection of the Prostate (TURP)—Incidence, Management, and PreventionEuropean Urology, 2006
- Holmium Laser Enucleation of the Prostate Versus Open Prostatectomy for Prostates >70g: 24-Month Follow-upEuropean Urology, 2006
- SAFETY AND EFFICACY OF TRANSURETHRAL RESECTION OF PROSTATE GLANDS UP TO 150 ML: A PROSPECTIVE COMPARATIVE STUDY WITH 1 YEAR OF FOLLOWUPJournal of Urology, 2004
- A prospective randomized trial evaluating tissue effects of finasteride therapy in benign prostatic hyperplasiaProstate Cancer and Prostatic Diseases, 1999